Related Experiment Video
Updated: Apr 26, 2026

09:02
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
11.4K
How the Pharmaceutical Benefits Scheme began.
1Hobart, TAS, Australia. martyng@netspace.net.au.
The Medical Journal of Australia
|July 23, 2014
Summary
Australia's Pharmaceutical Benefits Scheme (PBS) was established 70 years ago to ensure access to essential antibiotics. Despite initial opposition, the comprehensive PBS was realized by 1960.
Area of Science:
- Public Health
- Health Policy
- Pharmaceutical Policy
Background:
- The Curtin government introduced legislation for the Pharmaceutical Benefits Scheme (PBS) seventy years ago.
- The PBS aimed to provide access to newly available antibiotic drugs like penicillin to the entire Australian population.
- This initiative was a direct response to the limited accessibility of life-saving medications due to cost.
Observation:
- The proposed universal healthcare scheme faced immediate and significant opposition from the medical community and the conservative political parties.
- Opponents viewed the universal healthcare aspect as a move towards nationalizing the medical industry.
- The implementation of the comprehensive PBS involved considerable political and legal challenges, including High Court challenges, referendums, and a constitutional amendment.
Findings:
- Despite strong initial resistance, the legislative groundwork for the PBS was laid seventy years prior to its full realization.
- The comprehensive Pharmaceutical Benefits Scheme, as envisioned in 1944, was finally established in 1960.
- This marked a significant victory for universal access to essential medicines in Australia.
Implications:
- The PBS fundamentally reshaped pharmaceutical accessibility and affordability in Australia.
- It serves as a historical case study in the political and social challenges of implementing universal healthcare policies.
- The enduring success of the PBS underscores the importance of equitable access to medications for public health outcomes.
Related Concept Videos
Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Drug Products: Biologics, Biosimilars and Interchangeables
369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Biopharmaceutics and Pharmacokinetics: Overview
4.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.6K
Pharmaceutical Poisoning: Potential Scenarios
116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116

